文献速递临床试验与 GCP基础与转化研究

教育加运动对比皮质类固醇注射及等待观察对臀肌肌腱病的疗效:前瞻性单盲随机临床试验

Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial.
PubMed 文献 · BMJ · 2018-05-02

该研究在澳大利亚开展前瞻性三臂单盲随机对照试验,纳入204例临床及MRI确诊的臀肌肌腱病患者,比较教育加运动(EDX)、一次皮质类固醇注射(CSI)与等待观察(WS)的效果。8周时EDX和CSI的全局改善成功率及疼痛缓解均优于WS,且EDX优于CSI;52周时EDX全局改善仍优于CSI和WS,疼痛与CSI无差异但优于WS。结果支持EDX作为臀肌肌腱病的有效管理方案。

要点

  • 8周时EDX和CSI的全局改善及疼痛缓解均优于等待观察,且EDX优于CSI。
  • 52周时EDX全局改善优于CSI和WS,疼痛与CSI无差异但优于WS。
  • EDX可作为臀肌肌腱病的有效管理方案。

核心结论

  • 教育加运动和皮质类固醇注射在8周时均比不治疗带来更高的患者报告全局改善率和更低的疼痛强度。
  • 教育加运动在8周时表现优于皮质类固醇注射。
  • 52周随访时教育加运动全局改善优于皮质类固醇注射,但疼痛强度无差异。
  • 结果支持教育加运动作为臀肌肌腱病的有效管理方法。

研究设计与样本

  • 前瞻性、三臂、单盲、随机临床试验,在澳大利亚布里斯班和墨尔本开展。
  • 纳入204例35-70岁、外侧髋痛超过3个月、疼痛数字评分至少4/10、临床诊断及MRI确诊臀肌肌腱病的患者。
  • 干预为物理治疗主导的8周14次教育加运动项目(EDX;n=69)、一次皮质类固醇注射(CSI;n=66)和等待观察(WS;n=69)。
  • 主要结局为8周时患者报告的髋部状况全局变化评分(11分制,二分为成功/未成功)和过去一周疼痛强度(0=无痛,10=最痛),并随访至52周。

主要发现

  • 8周时全局变化成功人数:EDX 51/66,CSI 38/65,WS 20/68。
  • 8周时EDX和CSI全局改善优于WS,风险差分别为49.1%(95%CI 34.6%至63.5%)和29.2%(95%CI 13.2%至45.2%),需治疗人数分别为2.0(95%CI 1.6至2.9)和3.4(95%CI 2.2至7.6)。
  • 8周时EDX全局改善优于CSI,风险差19.9%(95%CI 4.7%至35.0%),需治疗人数5.0(95%CI 2.9至21.1)。
  • 8周时疼痛数字评分均值:EDX 1.5(SD 1.5),CSI 2.7(SD 2.4),WS 3.8(SD 2.0);EDX和CSI疼痛均低于WS,均差分别为-2.2(95%CI -2.89至-1.54)和-1.2(95%CI -1.85至-0.50);EDX疼痛低于CSI,均差-1.04(95%CI -1.72至-0.37)。
  • 52周时全局变化成功人数:EDX 51/65,CSI 36/63,WS 31/60;EDX优于CSI,风险差20.4%(95%CI 4.9%至35.9%),需治疗人数4.9(95%CI 2.8至20.6);EDX优于WS,风险差26.8%(95%CI 11.3%至42.3%),需治疗人数3.7(95%CI 2.4至8.8);52周疼痛评分EDX 2.1(SD 2.2),CSI 2.3(SD 1.9),WS 3.2(SD 2.6),EDX与CSI无差异(均差-0.26,95%CI -1.06至0.55),但两者均优于WS(均差分别为-1.13(95%CI -1.93至-0.33)和-0.87(95%CI -1.68至-0.07))。

临床怎么用

  • 对于臀肌肌腱病患者,可优先考虑物理治疗主导的教育加运动项目,其8周和52周全局改善均优于皮质类固醇注射。
  • 皮质类固醇注射在8周时可改善全局评分和疼痛,但52周全局改善不及教育加运动。
  • 等待观察在8周和52周的效果均劣于积极干预,不建议作为唯一管理策略。

局限性

  • 单盲设计,患者可能知晓分组。
  • 结果为患者报告结局,可能存在主观偏倚。
  • 未报告盲法评估者及分析方法的详细信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the effects of a programme of load management education plus exercise, corticosteroid injection use, and no treatment on pain and global improvement in individuals with gluteal tendinopathy. DESIGN: Prospective, three arm, single blinded, randomised clinical trial. SETTING: Brisbane and Melbourne, Australia. PARTICIPANTS: Individuals aged 35-70 years, with lateral hip pain for more than three months, at least 4/10 on the pain numerical rating scale, and gluteal tendinopathy confirmed by clinical diagnosis and magnetic resonance imaging; and with no corticosteroid injection use in previous 12 months, current physiotherapy, total hip replacement, or neurological conditions. INTERVENTIONS: A physiotherapy led education and exercise programme of 14 sessions over eight weeks (EDX; n=69), one corticosteroid injection (CSI; n=66), and a wait and see approach (WS; n=69). MAIN OUTCOMES: Primary outcomes were patient reported global rating of change in hip condition (on an 11 point scale, dichotomised to success and non-success) and pain intensity in the past week (0=no pain, 10=worst pain) at eight weeks, with longer term follow-up at 52 weeks. RESULTS: Of 204 randomised participants (including 167 women; mean age 54.8 years (standard deviation 8.8)), 189 (92.6%) completed 52 week follow-up. Success on the global rating of change was reported at eight weeks by 51/66 EDX, 38/65 CSI, and 20/68 WS participants. EDX and CSI had better global improvement scores than WS (risk difference 49.1% (95% confidence interval 34.6% to 63.5%), number needed to treat 2.0 (95% confidence interval 1.6 to 2.9); 29.2% (13.2% to 45.2%), 3.4 (2.2 to 7.6); respectively). EDX had better global improvement scores than CSI (19.9% (4.7% to 35.0%); 5.0 (2.9 to 21.1)). At eight weeks, reported pain on the numerical rating scale was mean score 1.5 (standard deviation 1.5) for EDX, 2.7 (2.4) for CSI, and 3.8 (2.0) for WS. EDX and CSI participants reported less pain than WS (mean difference -2.2 (95% confidence interval -2.89 to -1.54); -1.2 (-1.85 to -0.50); respectively), and EDX participants reported less pain than CSI (-1.04 (-1.72 to -0.37)). Success on the global rating of change was reported at 52 weeks by 51/65 EDX, 36/63 CSI, and 31/60 WS participants; EDX was better than CSI (20.4% (4.9% to 35.9%); 4.9 (2.8 to 20.6)) and WS (26.8% (11.3% to 42.3%); 3.7 (2.4 to 8.8)). Reported pain at 52 weeks was 2.1 (2.2) for EDX, 2.3 (1.9) for CSI, and 3.2 (2.6) for WS; EDX did not differ from CSI (-0.26 (-1.06 to 0.55)), but both treatments did better than WS (1.13 (-1.93 to -0.33); 0.87 (-1.68 to -0.07); respectively). CONCLUSIONS: For gluteal tendinopathy, education plus exercise and corticosteroid injection use resulted in higher rates of patient reported global improvement and lower pain intensity than no treatment at eight weeks. Education plus exercise performed better than corticosteroid injection use. At 52 week follow-up, education plus exercise led to better global improvement than corticosteroid injection use, but no difference in pain intensity. These results support EDX as an effective management approach for gluteal tendinopathy. TRIAL REGISTRATION: Prospectively registered at the Australian New Zealand Clinical Trials Registry (ACTRN12612001126808).

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Mellor R, Bennell K, Grimaldi A, et al. Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial. BMJ. 2018. PMID: 29720374. doi:10.1136/bmj.k1662

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。